DuPont de Nemours Inc. DD is advancing access to safe drinking water in Kenya by deploying its membrane-based treatment solutions in Baringo County, specifically in the remote community of Kampi ya Samaki.
The initiative is being carried out in collaboration with ChildFund International. The organization plays a key role in engaging with the local community. It supports the on-ground implementation of the project and works to ensure that the solution addresses the needs of vulnerable populations. It encourages community participation to improve long-term adoption.
The project uses DuPont’s IntegraTec Ultrafiltration technology. It removes bacteria, viruses, and suspended solids through low-pressure filtration, along with DuPont’s FilmTec reverse osmosis membranes to eliminate dissolved salts and chemical contaminants where necessary.
The initiative is designed to benefit around 20,000 people in Kampi ya Samaki and nearby areas, where access to clean water has been limited due to poor infrastructure and contamination of local sources.
This collaboration highlights a scalable approach to improving water security and public health in underserved regions by combining advanced filtration technology with strong community partnerships.
Shares of DD have fallen 40.7% in the past year against the industry’s 3.7% growth.
Image Source: Zacks Investment Research
DD’s Zacks Rank & Other Key Picks
DD currently sports a Zacks Rank #1 (Strong Buy).
Other top-ranked stocks in the Basic Materials space are Compass Minerals International, Inc. CMP, Johnson Matthey Plc JMPLY and Asahi Kasei Corporation AHKSY. CMP flaunts a Zacks Rank of 1, while JMPLY and AHKSY have a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for CMP’s current fiscal-year earnings is pegged at 89 cents per share, indicating a 285.42% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in two of the trailing four quarters while missing twice, with an average surprise of 35%.
The Zacks Consensus Estimate for JMPLY’s current fiscal-year earnings stands at $3.32 per share, implying a 13% year-over-year decrease. Shares of JMPLY have surged 43.3% over the past year.
The Zacks Consensus Estimate for AHKSY’s current fiscal-year earnings is pegged at $1.38 per share, indicating a 8% year-over-year increase. Shares of AHKSY have surged 35.5% over the past year.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpDuPont de Nemours, Inc. (DD) : Free Stock Analysis Report
Compass Minerals International, Inc. (CMP) : Free Stock Analysis Report
Asahi Kasei Corp. (AHKSY) : Free Stock Analysis Report
Johnson Matthey PLC (JMPLY) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
